Cargando…

New anti HCV drugs in the pipeline

Detalles Bibliográficos
Autor principal:	Bourlière, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316049/ http://dx.doi.org/10.1186/1742-4690-7-S1-I24

Ejemplares similares

New anti-HCV agents in the pipeline
por: Zoulim, Fabien
Publicado: (2014)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

New drug interactions in HIV and HCV
por: Back, David
Publicado: (2012)

HCV resistance
por: Halfon, Philippe
Publicado: (2012)

Diffusion of new antiretroviral drugs in CSF
por: Aweeka, Francesca
Publicado: (2010)

Resistance to new antiretrovirals (ETV, anti-integrases, entry inhibitors)
por: Ceccherini-Silberstein, Francesca
Publicado: (2010)

Use of new technologies to detect and understand HIV drug resistance
por: Kozal, Michael J
Publicado: (2010)

Managing HCV infection: present and future
por: Rockstroh, Jürgen K
Publicado: (2014)

Drug-drug interactions: it is not only CYP450's which matter
por: Back, David J
Publicado: (2010)

Universal access to anti-HIV therapy
por: Souteyrand, Yves
Publicado: (2012)

Anti-latency agents to purge HIV reservoirs
por: Moreno, Santiago
Publicado: (2012)

Evidence-based TDM for antiretroviral drugs
por: Solas, Caroline
Publicado: (2010)

Analgesic drug development: time to break the mould
por: Woolf, Clifford
Publicado: (2013)

New antiretrovirals
por: Gulick, Roy
Publicado: (2012)

Transporters used by parasites as drug targets: tempting but underexploited
por: Staines, Henry
Publicado: (2010)

Rehabilitation from symptomatic drugs overuse: yes, no, may be
por: Tassorelli, Cristina, et al.
Publicado: (2015)

S38. Many reasons for combining immunotherapy with chemotherapy to enhance anti tumour response
por: Dalgleish, A, et al.
Publicado: (2014)

Type 1 diabetes - an auto-inflammatory disease: a new concept, new therapeutical strategies
por: Limbert, Catarina
Publicado: (2012)

S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4
por: Sharma, P
Publicado: (2014)

S49. Clinical activity and development of biomarkers for an engineered anti PDL1 antibody MPDL3280A
por: Cha, E
Publicado: (2014)

What is new in the treatment of eosinophilic eosophagitis?
por: Assa'ad, Amal
Publicado: (2011)

New therapeutic perspectives – amyloid removal
por: Pepys, Mark
Publicado: (2015)

New medicines to improve control and contribute to the eradication of malaria
por: Wells, Timothy NC
Publicado: (2010)

Retroviral restriction factors: new mechanisms of innate immunity
por: Wolf, Daniel, et al.
Publicado: (2009)

Finding new immune regulatory genes by ENU mutagenesis
por: Enders, Anselm, et al.
Publicado: (2012)

New tools to diagnose and follow FAC patients: biomarkers
por: Merlini, Giampaolo
Publicado: (2015)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

Use of new resistance markers to predict virologic response to antiretrovirals
por: Wainberg, Mark A, et al.
Publicado: (2010)

New perspectives on immunological pathways underlying peanut-induced anaphylaxis
por: Jordana, Manel
Publicado: (2011)

PReS13-SPK-1240: New aspects on APS pathogenesis
por: Meroni, PL
Publicado: (2013)

Impact of a new European regulations on functional food market – an overview
por: Lovik, Martinus
Publicado: (2011)

PReS13-SPK-1034: looking for new monogenic forms of lupus
por: Crow, Y
Publicado: (2013)

S6. Proffered paper: Anti-tumour immunomodulatory activity of heat shock protein Hsp70 in therapy of malignant brain tumours: preclinical and clinical data
por: Shevtsov, M, et al.
Publicado: (2014)

Food allergen protein families and their structural characteristics: new data from Europrevail
por: Hoffmann-Sommergruber, Karin
Publicado: (2011)

PReS13-SPK-1253: Challenges in nursing care with the new biologics for JIA
por: Livermore, P
Publicado: (2013)

PReS13-SPK-1137: New developments in our care & understanding of JIA
por: Beresford, MW
Publicado: (2013)

PReS13-SPK-1478: New developments in our care & understanding of JIA
por: Wedderburn, L
Publicado: (2013)

New ARV drugs
por: Gulick, Roy
Publicado: (2014)

Statistical validation of surrogate outcome measures
por: Buyse, Marc
Publicado: (2011)

Intestinal immunity marches on its stomach
por: Veldhoen, Marc
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7got83c502tn17d049v0r89rc1